Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study

Jeremy Marsden (Lead / Corresponding author), R Fox, N M Boota, M Cook, K Wheatley, L J Billingham, N M Steven (Lead / Corresponding author), NCRI Skin Cancer Clinical Studies Group, U.K. Dermatology Clinical Trials Network, LIMIT-1 Collaborative Group

    Research output: Contribution to journalArticle

    15 Citations (Scopus)
    159 Downloads (Pure)

    Fingerprint Dive into the research topics of 'Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study'. Together they form a unique fingerprint.

    Medicine & Life Sciences